IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney disease: drug aims to slow damage in IgA nephropathy
Disease control OngoingThis phase 3 study tests a drug called atacicept in 376 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if atacicept can reduce protein in the urine and slow the decline in kidney function compared to a placebo. Participants must …
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for kidney disease: BION-1301 trial underway
Disease control OngoingThis study tests a new medicine called BION-1301 in healthy people and adults with IgA nephropathy, a kidney disease. The goal is to check if the drug is safe and how the body processes it. About 103 participants will be involved in this early-stage trial.
Matched conditions: IGA NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC